Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the effect of epoetin alfa on anemia in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Multiple Myeloma

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Multiple Myeloma | Phase 3 | Status: COMPLETED